Selected characteristics of the persons in the study cohorts.

*Pamidronic acid, alendronic acid, ibandronic acid, risedronic acid, zoledronic acid, risedronic acid in combination preparation with calcium, or risedronic acid with calcium and cholecalsiferol.†Etidronic acid, clodronic acid, tiludronic acid, or etidronic acid with calcium.‡As indicated in the Special Reimbursement Register of the Social Insurance Institution in Finland.*帕米膦酸（Pamidronic acid）、阿仑膦酸（alendronic acid）、伊班膦酸（ibandronic acid）、利塞膦酸（risedronic acid）、唑来膦酸（zoledronic acid）、与钙联用的利塞膦酸复方制剂，或利塞膦酸与钙及胆钙化醇（cholecalsiferol）的复方制剂。†依替膦酸（etidronic acid）、氯膦酸（clodronic acid）、替鲁膦酸（tiludronic acid），或与钙联用的依替膦酸。‡按照芬兰社会保险机构特殊报销登记册中的相关规定。